Nathan Sorenson, an MS candidate in Biotechnology, sits down with the College of Science Graduate Program staff to talk about what it’s like to study at Northeastern University.
190 Massachusetts high school students participated in Biotech Futures, a college and career exploration event that exposes students to the educational opportunities and diverse fields of study in the life sciences at the college level through hands-on laboratory experiences and campus tours.
As Dean of the College of Science I wish to reach out and offer the support of our community to those students, staff and faculty who are potentially affected by the recent Immigration Executive Order.
Ritika Kukreja, a final year MS Biotechnology student at the College of Science, Northeastern University, Boston shares her Pre-Co-Op experience.
Last month, a pipeline agreement was finalized between Northeastern University’s Biotechnology program and Loyola University Maryland to streamline the admissions process for prospective Master’s students.
For many, reading about complex scientific research and innovation can be a daunting task. But the students behind NU Sci—Northeastern’s student-run science magazine—are working to change that.
The College of Science Graduate Program staff sat down with Vanecia Harrison-Sanders and Patricia Corrigan to discuss their work in graduate co-op.
Kenneth Henderson can point to the moment when his career spun in an exciting new direction: a five-month industry placement in London prior to his senior year of college. Here, the new College of Science dean discusses the importance of experiential education and his vision for the college.
John de la Parra has a goal of using his love of plants to find new medicines from indigenous cultural practices and then bring in the full power of modern biotechnology to create a a controllable platform to create the medicines desperately needed for disease.
Boston is the apex of today’s biotechnology world. With over 250 companies in Boston, Cambridge, and surrounding suburbs, nearly every pharmaceutical company has a stake in Boston’s biotech network.